InterSystems IRIS

  Oncodesign collaborates with InterSystems to accelerate Drug Discovery in Oncology Today’s oncology discovery involves the concept of personalized medicine to oncological research and engagement of specialists form their fields to gain insights into pharmacology. On May 18,2021, InterSystems , a leading data management company in healthcare, financial and logistics sectors has announced a new long-term partnership with Oncodesign, a biotechnology and biopharmaceutical company based in Paris, France. This collaboration will involve Oncosign adapt InterSystems ’ solutions to utilize and organize health data to catalyze their medical search for advanced treatments and discovery of drug formulations in Oncology using Artificial Intelligence (AI). Oncosnipe®, Oncodesign’s patented platform to identify and validate new therapeutic targets will integrate with InterSystems IRIS for Health™ under this collaboration. The process would involve Oncodesign establish an AI business uni...

  InterSystems IRIS for Health advances Defense Medical Information System Formerly known as Abacus Technology, Maestro is the most preferred tray-tracking system in healthcare industry that provides both small clinics and large hospitals with tools to organize workforce planning, advance tray assembly on basis of cases and communicate warnings about inventory issues which are operated by IBM Watson Analytics. Because of its flexible pricing schemes based on various requirements, budgets and instrument contracts, Maestro is now opted by over 550 hospitals around the globe. This is mainly because the program uses InterSystems IRIS for Health which is the only data platform in the world that is specially designed to extract values from health data to create scale-breaking and information-rich health applications. Besides this, it also uses InterSystems HealthShare , an interoperability platform that normalizes, aggregates and deduplicates data from longitudinal and standardized ...